Freedom Investment Management Inc. lowered its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,745 shares of the financial services provider’s stock after selling 165 shares during the period. Freedom Investment Management Inc.’s holdings in MetLife were worth $804,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also made changes to their positions in MET. Great Valley Advisor Group Inc. increased its position in MetLife by 1.3% during the third quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider’s stock worth $781,000 after buying an additional 123 shares during the period. Abacus Planning Group Inc. increased its holdings in shares of MetLife by 1.0% in the 3rd quarter. Abacus Planning Group Inc. now owns 12,301 shares of the financial services provider’s stock valued at $1,015,000 after acquiring an additional 127 shares during the period. Avestar Capital LLC raised its position in MetLife by 3.2% in the 3rd quarter. Avestar Capital LLC now owns 4,264 shares of the financial services provider’s stock valued at $352,000 after purchasing an additional 133 shares during the last quarter. Financial Management Professionals Inc. grew its position in MetLife by 2.0% during the 3rd quarter. Financial Management Professionals Inc. now owns 6,984 shares of the financial services provider’s stock worth $576,000 after purchasing an additional 136 shares during the last quarter. Finally, Ameliora Wealth Management Ltd. increased its stake in MetLife by 1.7% in the third quarter. Ameliora Wealth Management Ltd. now owns 8,548 shares of the financial services provider’s stock valued at $705,000 after purchasing an additional 139 shares during the period. 89.81% of the stock is owned by hedge funds and other institutional investors.
MetLife Price Performance
Shares of NYSE MET opened at $88.25 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market cap of $61.11 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.79 and a beta of 1.05. The company’s 50-day moving average price is $83.19 and its 200 day moving average price is $76.46. MetLife, Inc. has a 52 week low of $62.89 and a 52 week high of $89.05.
MetLife Announces Dividend
Analyst Ratings Changes
Several equities research analysts have recently weighed in on the stock. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Monday. Jefferies Financial Group lifted their target price on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Barclays cut their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Piper Sandler raised their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, MetLife presently has an average rating of “Buy” and a consensus price target of $88.62.
View Our Latest Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Industrial Products Stocks Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 10 Best Airline Stocks to Buy
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Financial Services Stocks Investing
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.